King Edward Memorial Hospital and Seth Gordhandas Sunderdas Medical College

Children’s Hospital Los Angeles Names Sucheta Joshi, MD, MS, FAAP, FAES as Incoming Medical Director of Comprehensive Epilepsy Program

Retrieved on: 
Thursday, June 29, 2023

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20230629162494/en/
    Sucheta Joshi, MD, MS, FAAP, FAES, has been named as incoming Medical Director of the Neurological Institute Comprehensive Epilepsy Program at Children’s Hospital Los Angeles (CHLA).
  • She most recently has served as Service Chief of Pediatric Neurology and Medical Director of Pediatric Epilepsy at Michigan Medicine, the academic medical center of the University of Michigan, where she launched a complex epilepsy clinical program and an inpatient pediatric epilepsy service.
  • In her new role, Dr. Joshi will lead and expand the Comprehensive Epilepsy Program at CHLA and will grow programs such as telehealth, precision health trials, adult transition, team-based clinics and surgical epilepsy.
  • Joshi’s leadership will help us reach the full potential of our Comprehensive Epilepsy Program.

Obsidian Therapeutics Announces Dr. Madan Jagasia as Chief Executive Officer and Other Leadership Appointments

Retrieved on: 
Tuesday, May 23, 2023

Obsidian Therapeutics Inc. , a clinical-stage biotechnology company pioneering engineered cell and gene therapies, today announced the appointment of Madan Jagasia, M.D., M.S., as Chief Executive Officer.

Key Points: 
  • Obsidian Therapeutics Inc. , a clinical-stage biotechnology company pioneering engineered cell and gene therapies, today announced the appointment of Madan Jagasia, M.D., M.S., as Chief Executive Officer.
  • Before Iovance, he was Chief Medical Officer and Executive Medical Director of Cancer Patient Care Center, Vanderbilt-Ingram Cancer Center (VICC), where he co-led Translational Research and Interventional Oncology Research Program at VICC.
  • Dr. Jagasia began his career as a faculty member in the Division of Hematology-Oncology at Vanderbilt University Medical Center.
  • Dr. Norkunas is an experienced biotechnology executive, currently serving as Chief Financial Officer at Generation Bio.

MPS announces Q4 and FY23 results; Revenue crosses INR 500 crores, and PAT up by 25% YoY at INR 109 crores

Retrieved on: 
Tuesday, May 16, 2023

CHENNAI, Tamil Nadu, May 16, 2023 /PRNewswire-PRWeb/ -- MPS Limited (BSE: 532440; NSE: MPS LTD), a premium B2B learning and platform solutions company that powers the education, research, and corporate markets is announcing consolidated financial results for Q4 and FY23. The results were taken on record at the meeting of the Board of Directors held on May 16, 2023.

Key Points: 
  • The business surpassed its publicly stated goal of INR 100 crores in PAT and ended much ahead at INR 109 crores in FY23.
  • Q4 FY'23 revenues were up 16.5% YoY on Reported terms and 15.7% YoY on FX Adjusted terms.
  • Speaking on the performance, Rahul Arora, Chairman and CEO at MPS Limited, said, "MPS achieved a new milestone with FX-Adjusted Revenues at INR 500 crores in FY23.
  • We also surpassed our publicly stated goal of INR 100 crores in PAT and ended much ahead at INR 109 crores in FY23.

Padma Doniparthi, MD, DABA, DABPM, AAHPC, Joins Pain Specialists of America in Temple and Georgetown, TX

Retrieved on: 
Tuesday, September 6, 2022

Dr. Doniparthi is a best-in-class, triple board-certified interventional pain management physician with over 20 years of excellence.

Key Points: 
  • Dr. Doniparthi is a best-in-class, triple board-certified interventional pain management physician with over 20 years of excellence.
  • She has relocated to the Georgetown community from Brookfield, WI, where she practiced interventional pain medicine.
  • Dr. Padma Doniparthi is a diplomate of the American Board of Anesthesiology, Pain Management and Hospice and Palliative Care.
  • About Pain Specialists of America:
    Pain Specialists of America is an interventional pain management group with highly educated, double and triple-board-certified pain physicians.

Alligator Bioscience Appoints Sumeet Ambarkhane MD as Chief Medical Officer

Retrieved on: 
Tuesday, February 1, 2022

LUND, Sweden, Feb. 1, 2022 /PRNewswire/ --Alligator Bioscience (Nasdaq Stockholm: ATORX)Alligator Bioscience (Nasdaq Stockholm: ATORX), today announces the appointment of Sumeet Ambarkhane, MD, as its Chief Medical Officer.

Key Points: 
  • LUND, Sweden, Feb. 1, 2022 /PRNewswire/ --Alligator Bioscience (Nasdaq Stockholm: ATORX)Alligator Bioscience (Nasdaq Stockholm: ATORX), today announces the appointment of Sumeet Ambarkhane, MD, as its Chief Medical Officer.
  • Sumeet comes to Alligator fromMorphoSys AG, where he served as their Senior Global Program Medical Director.
  • Sumeet holds a Bachelor of Medicine, Bachelor of Surgery and Medical Doctorate degrees in medicine and clinical pharmacology from Seth G.S.
  • "We are thrilled to welcome a professional of Sumeet's caliber to the Alligator team," says Sren Bregenholt, CEO, Alligator Bioscience.

Alligator Bioscience Appoints Sumeet Ambarkhane MD as Chief Medical Officer

Retrieved on: 
Tuesday, February 1, 2022

LUND, Sweden, Feb. 1, 2022 /PRNewswire/ --Alligator Bioscience (Nasdaq Stockholm: ATORX)Alligator Bioscience (Nasdaq Stockholm: ATORX), today announces the appointment of Sumeet Ambarkhane, MD, as its Chief Medical Officer.

Key Points: 
  • LUND, Sweden, Feb. 1, 2022 /PRNewswire/ --Alligator Bioscience (Nasdaq Stockholm: ATORX)Alligator Bioscience (Nasdaq Stockholm: ATORX), today announces the appointment of Sumeet Ambarkhane, MD, as its Chief Medical Officer.
  • Sumeet comes to Alligator fromMorphoSys AG, where he served as their Senior Global Program Medical Director.
  • Sumeet holds a Bachelor of Medicine, Bachelor of Surgery and Medical Doctorate degrees in medicine and clinical pharmacology from Seth G.S.
  • "We are thrilled to welcome a professional of Sumeet's caliber to the Alligator team," says Sren Bregenholt, CEO, Alligator Bioscience.